However, like any intravenous treatment, it carries minor risks, including: Temporary nausea or dizziness Allergic reactions (rare) Skin rashes Mild pain at injection site Dr
Multiple studies have shown that diabetes is associated with cognitive impairment, in which HO-1 as an important antioxidant enzyme, plays an important role in protecting against apoptosis, inflammation, and oxidative stress in diabetic cognitive dysfunction [162,163,164]
It may not make sense to stay on this medication if it will make those symptoms worse
Third, as we will detail below (see Potential Pathogenic Mechanisms of Hyperhomocysteinemia), our own work (Durand et al, 1997a) and the work of Lentz et al (1996) and Bellamy et al (1998) give experimental evidence that moderate hyperhomocysteinemia, which leads to vascular dysfunction, might increase the cardiovascular risk independently of other risk factors
If you are struggling with your weight and feel your concerns are not being addressed, you have the right to ask for a second opinion or a referral to a specialist obesity service
"Unsustainable burden" Blue Cross Blue Shield said in 2024, five GLP-1 drug companies accounted for 20% of their total pharmacy spend which topped $300 million last year